Nathan LaCross

1.4k total citations · 1 hit paper
16 papers, 812 citations indexed

About

Nathan LaCross is a scholar working on Infectious Diseases, Epidemiology and Microbiology. According to data from OpenAlex, Nathan LaCross has authored 16 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Microbiology. Recurrent topics in Nathan LaCross's work include Pneumonia and Respiratory Infections (6 papers), SARS-CoV-2 detection and testing (6 papers) and Biosensors and Analytical Detection (5 papers). Nathan LaCross is often cited by papers focused on Pneumonia and Respiratory Infections (6 papers), SARS-CoV-2 detection and testing (6 papers) and Biosensors and Analytical Detection (5 papers). Nathan LaCross collaborates with scholars based in United States. Nathan LaCross's co-authors include Carl F. Marrs, Janet R. Gilsdorf, Phillip E. Heck, Zachary T. Aanderud, James VanDerslice, Kevin T. Torgersen, Rubayat Jamal, Yue Zhang, Jennifer Weidhaas and D. Keith Roper and has published in prestigious journals such as The Science of The Total Environment, Journal of Bacteriology and Journal of Clinical Microbiology.

In The Last Decade

Nathan LaCross

15 papers receiving 791 citations

Hit Papers

Correlation of SARS-CoV-2 RNA in wastewater with COVID-19... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan LaCross United States 11 481 254 162 125 90 16 812
Mi Seon Han South Korea 14 395 0.8× 74 0.3× 222 1.4× 75 0.6× 92 1.0× 40 763
Brett Whitaker United States 13 562 1.2× 195 0.8× 273 1.7× 18 0.1× 36 0.4× 37 1.1k
Alison Hardie United Kingdom 14 579 1.2× 82 0.3× 479 3.0× 55 0.4× 68 0.8× 24 1.0k
Jiehao Cai China 12 724 1.5× 33 0.1× 166 1.0× 31 0.2× 53 0.6× 26 944
Sam Douthwaite United Kingdom 11 458 1.0× 104 0.4× 203 1.3× 7 0.1× 90 1.0× 44 916
Andrew F. Brouwer United States 15 221 0.5× 44 0.2× 197 1.2× 22 0.2× 82 0.9× 68 856
Eloise Williams Australia 15 210 0.4× 46 0.2× 176 1.1× 47 0.4× 17 0.2× 49 569
Cari van Schalkwyk South Africa 15 818 1.7× 24 0.1× 328 2.0× 29 0.2× 164 1.8× 42 1.1k
Emily Landon United States 16 312 0.6× 21 0.1× 254 1.6× 51 0.4× 27 0.3× 40 888
Wing‐Kin To China 14 789 1.6× 37 0.1× 210 1.3× 18 0.1× 152 1.7× 22 1.0k

Countries citing papers authored by Nathan LaCross

Since Specialization
Citations

This map shows the geographic impact of Nathan LaCross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan LaCross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan LaCross more than expected).

Fields of papers citing papers by Nathan LaCross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan LaCross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan LaCross. The network helps show where Nathan LaCross may publish in the future.

Co-authorship network of co-authors of Nathan LaCross

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan LaCross. A scholar is included among the top collaborators of Nathan LaCross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan LaCross. Nathan LaCross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Crank, Katherine, et al.. (2024). Early Introductions of Candida auris Detected by Wastewater Surveillance, Utah, USA, 2022–2023. Emerging infectious diseases. 30(10). 2107–2117.
2.
Iverson, Thomas J., et al.. (2023). Candida auris Discovery through Community Wastewater Surveillance during Healthcare Outbreak, Nevada, USA, 2022. Emerging infectious diseases. 29(2). 422–425. 24 indexed citations
3.
Gupta, Pooja, et al.. (2023). Wastewater Genomic Surveillance Captures Early Detection of Omicron in Utah. Microbiology Spectrum. 11(3). e0039123–e0039123. 15 indexed citations
4.
Weidhaas, Jennifer, Zachary T. Aanderud, D. Keith Roper, et al.. (2021). Correlation of SARS-CoV-2 RNA in wastewater with COVID-19 disease burden in sewersheds. The Science of The Total Environment. 775. 145790–145790. 237 indexed citations breakdown →
5.
Lewis, Nathaniel M., Rebecca B. Hershow, Victoria Chu, et al.. (2021). Factors Associated with Participation in Elementary School–Based SARS-CoV-2 Testing — Salt Lake County, Utah, December 2020–January 2021. MMWR Morbidity and Mortality Weekly Report. 70(15). 557–559. 5 indexed citations
6.
McClary-Gutierrez, Jill S., Mia Mattioli, Perrine Marcenac, et al.. (2021). SARS-CoV-2 Wastewater Surveillance for Public Health Action. Emerging infectious diseases. 27(9). 1–8. 80 indexed citations
7.
Kirby, Amy, Maroya Spalding Walters, Wiley C. Jennings, et al.. (2021). Using Wastewater Surveillance Data to Support the COVID-19 Response — United States, 2020–2021. MMWR Morbidity and Mortality Weekly Report. 70(36). 1242–1244. 106 indexed citations
8.
Arons, Melissa, Stephen Barnes, David Bui, et al.. (2020). Examining the temporality of vitamin E acetate in illicit THC-containing e-cigarette, or vaping, products from a public health and law enforcement response to EVALI — Utah, 2018-2020. International Journal of Drug Policy. 88. 103026–103026. 6 indexed citations
9.
Bui, David, Keegan McCaffrey, Michael Friedrichs, et al.. (2020). Racial and Ethnic Disparities Among COVID-19 Cases in Workplace Outbreaks by Industry Sector — Utah, March 6–June 5, 2020. MMWR Morbidity and Mortality Weekly Report. 69(33). 1133–1138. 108 indexed citations
10.
Lewis, Nathaniel M., Nathan LaCross, David Bui, et al.. (2020). Disparities in COVID-19 Incidence, Hospitalizations, and Testing, by Area-Level Deprivation — Utah, March 3–July 9, 2020. MMWR Morbidity and Mortality Weekly Report. 69(38). 1369–1373. 71 indexed citations
12.
LaCross, Nathan, Carl F. Marrs, & Janet R. Gilsdorf. (2014). Otitis media associated polymorphisms in the hemin receptor HemR of nontypeable Haemophilus influenzae. Infection Genetics and Evolution. 26. 47–57. 8 indexed citations
13.
LaCross, Nathan, Carl F. Marrs, & Janet R. Gilsdorf. (2012). Population structure in nontypeable Haemophilus influenzae. Infection Genetics and Evolution. 14(3). 125–136. 27 indexed citations
14.
LaCross, Nathan, Carl F. Marrs, Mayuri Patel, Sara A. Sandstedt, & Janet R. Gilsdorf. (2008). High Genetic Diversity of Nontypeable Haemophilus influenzae Isolates from Two Children Attending a Day Care Center. Journal of Clinical Microbiology. 46(11). 3817–3821. 23 indexed citations
15.
Day, Sharlene M., Pierre Coutu, Wang Wang, et al.. (2008). Cardiac-directed parvalbumin transgene expression in mice shows marked heart rate dependence of delayed Ca2+buffering action. Physiological Genomics. 33(3). 312–322. 7 indexed citations
16.
McCrea, Kirk W., Jingping Xie, Nathan LaCross, et al.. (2007). Relationships of Nontypeable Haemophilus influenzae Strains to Hemolytic and Nonhemolytic Haemophilus haemolyticus Strains. Journal of Clinical Microbiology. 46(2). 406–416. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026